| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 32 |
| 1 | METHOTREXATE SODIUM | 24 |
| 2 | METHOTREXATE | 22 |
| 3 | OMEPRAZOLE MAGNESIUM | 22 |
| 4 | METHYLPREDNISOLONE | 20 |
| 5 | OMEPRAZOLE | 19 |
| 6 | ADALIMUMAB | 18 |
| 7 | AMLODIPINE | 18 |
| 8 | PREGABALIN | 18 |
| 9 | ALENDRONATE SODIUM | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL | 2 | 0.0084 |
| 1 | NITAZOXANIDE | 2 | 0.0057 |
| 2 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 3 | ACETIC ACID | 1 | 0.0028 |
| 4 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 5 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 2 | 0.0018 |
| 6 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 7 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0017 |
| 8 | POTASSIUM NITRATE, SODIUM FLUORIDE | 1 | 0.0016 |
| 9 | TEPLIZUMAB-MZWV | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 75 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 2 | Benzodiazepine [EPC] | 32 |
| 3 | Proton Pump Inhibitor [EPC] | 30 |
| 4 | Kinase Inhibitor [EPC] | 23 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 22 |
| 6 | Azole Antifungal [EPC] | 18 |
| 7 | Calcium Channel Blocker [EPC] | 18 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 18 |
| 9 | Aromatase Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 4 | Stimulant Laxative [EPC] | 6 | 0.0004 |
| 5 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 8 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 9 | Antiparasitic [EPC] | 1 | 0.0002 |